Tianjin Chase Sun Pharmaceutical Co Ltd - Class A

SZSE:300026 (China)   Class A
Â¥ 3.25 (+0.62%) Jun 18
25.00
P/B:
1.11
Market Cap:
Â¥ 9.76B ($ 1.35B)
Enterprise V:
Â¥ 9.67B ($ 1.33B)
Volume:
20.29M
Avg Vol (2M):
26.99M
Trade In:
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Tianjin Chase Sun Pharmaceutical Co Ltd ( ) from 2009 to Jun 18 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Tianjin Chase Sun Pharmaceutical stock (SZSE:300026) PE ratio as of Jun 18 2024 is 25. More Details

Tianjin Chase Sun Pharmaceutical Co Ltd (SZSE:300026) PE Ratio (TTM) Chart

To

Tianjin Chase Sun Pharmaceutical Co Ltd (SZSE:300026) PE Ratio (TTM) Historical Data

Total 1206
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Tianjin Chase Sun Pharmaceutical PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-06-18 25.0 2024-04-10 29.2
2024-06-17 24.9 2024-04-09 29.9
2024-06-14 25.1 2024-04-08 29.5
2024-06-13 25.2 2024-04-03 30.4
2024-06-12 26.0 2024-04-02 30.6
2024-06-11 26.1 2024-04-01 30.7
2024-06-07 26.4 2024-03-29 30.1
2024-06-06 25.9 2024-03-28 30.0
2024-06-05 27.0 2024-03-27 22.8
2024-06-04 27.4 2024-03-26 23.1
2024-06-03 27.6 2024-03-25 22.8
2024-05-31 27.9 2024-03-22 23.2
2024-05-30 27.8 2024-03-21 23.8
2024-05-29 27.5 2024-03-20 23.9
2024-05-28 27.5 2024-03-19 23.8
2024-05-27 27.9 2024-03-18 24.2
2024-05-24 27.8 2024-03-15 23.8
2024-05-23 27.9 2024-03-14 23.8
2024-05-22 28.6 2024-03-13 23.8
2024-05-21 28.5 2024-03-12 24.2
2024-05-20 28.9 2024-03-11 23.2
2024-05-17 28.9 2024-03-08 22.9
2024-05-16 28.9 2024-03-07 22.8
2024-05-15 29.1 2024-03-06 22.9
2024-05-14 29.5 2024-03-05 23.1
2024-05-13 29.4 2024-03-04 23.5
2024-05-10 29.8 2024-03-01 23.3
2024-05-09 30.3 2024-02-29 23.4
2024-05-08 30.2 2024-02-28 22.9
2024-05-07 30.0 2024-02-27 23.9
2024-05-06 30.0 2024-02-26 23.6
2024-04-30 29.7 2024-02-23 23.2
2024-04-29 29.2 2024-02-22 23.2
2024-04-26 28.4 2024-02-21 22.9
2024-04-25 28.7 2024-02-20 23.0
2024-04-24 28.5 2024-02-19 22.8
2024-04-23 28.4 2024-02-08 23.0
2024-04-22 28.5 2024-02-07 22.9
2024-04-19 28.4 2024-02-06 21.2
2024-04-18 28.3 2024-02-05 18.9
2024-04-17 28.5 2024-02-02 19.8
2024-04-16 27.6 2024-02-01 20.8
2024-04-15 28.5 2024-01-31 21.1
2024-04-12 28.5 2024-01-30 21.9
2024-04-11 29.1 2024-01-29 22.5

Tianjin Chase Sun Pharmaceutical Co Ltd (SZSE:300026) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Tianjin Chase Sun Pharmaceutical Co Ltd is a high-tech medicine and health industry group. The company offers Chinese herb preparation products, medicinal granules, synthetic drugs, biotech drugs, medical apparatus, and Internet-based therapy.